Human CD4+ T-cell epitope-based therapeutic for peanut allergy [ 2011 - 2013 ]

Research Grant

Researchers: Prof Robyn O'Hehir (Principal investigator) ,  E/Pr Jennifer Rolland

Brief description Peanut allergy affects ~2% of the population and peanuts are the major cause of fatal food-induced anaphylaxis. Peanut allergy usually appears in infancy and persists indefinitely. At present, unlike grass pollen allergy, there is no preventative treatment. Using blood cells from peanut-allergic patients, we will identify the components of major peanut allergens to use in _allergy shots� to develop tolerance on peanut exposure without risking anaphylaxis.

Funding Amount $AUD 403,121.87

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant